MD Anderson Cancer Center of Orlando — Orlando, Florida

MD Anderson Cancer Center of Orlando is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center of Orlando has participated in 2 clinical trials.

Therapeutic areas: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: Millennium Pharmaceuticals, Inc., Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center of Orlando?

MD Anderson Cancer Center of Orlando has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center of Orlando conducted?

MD Anderson Cancer Center of Orlando has 2 clinical trials on record. Their work covers Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL), Ovarian Cancer, Fallopian Tube Cancer.

Is MD Anderson Cancer Center of Orlando accredited by Crixeo Health?

MD Anderson Cancer Center of Orlando has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center of Orlando?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.